Skip to main content

Alan Tubbs receives the D. Gordon Sharp Graduate Innovator Award

March 15, 2018

  The Department of Microbiology and Immunology is pleased to announce that Alan Tubbs is the 2018 recipient of the $500 D. Gordon Sharp Graduate Innovator Award. For his dissertation research, Alan conducted two distinct investigations that each substantially expanded topics under study in Ed Miao’s lab. Alan’s first project demonstrated that a high salt … Read more

Ashley Bone and Gabrielle Grandchamp: 2018 Horizon Awardees

March 10, 2018

Congratulations to Ashley Bone (M&I predoctoral student in Peggy Cotter‘s lab) and Gabrielle Grandchamp (M&I predoctoral student in Beth Shank‘s lab), recipients of this year’s Horizon Awards from the UNC Graduate School. The Horizon Award recognizes graduate students who have made “discoveries with future potential to benefit North Carolina (and beyond).” Ashley and Gabrielle were … Read more

David Margolis, Sarah Graham Kenan Distinguished Professor

March 6, 2018

Congratulations to M&I Professor David Margolis, who has been honored with a Sarah Graham Kenan endowed professorship from UNC’s School of Medicine:

NIH research funding: UNC’s M&I now ranks 3rd among peer departments nationwide

March 2, 2018

Each year, NIH funding to U.S. medical schools is made public, including a department-by-department breakdown of the award data. The grant analysis for fiscal year 2017 has just been released (see, and UNC’s Department of Microbiology & Immunology now ranks 3rd among its peers (i.e., microbiology departments at public university medical schools). Ten years … Read more

U.S. News “Best Global Universities” ranks UNC Microbiology & Immunology in the top 5 among its peers

February 9, 2018

Each year, U.S. News publishes rankings of the “Best Global Universities,” designed to provide international context for a university’s academic research and reputation. Surveys and metrics are used to rank the top 1250 institutions spanning 74 countries and also to assess the strengths of 22 subject areas. For the subject area of microbiology, UNC currently … Read more

Four M&I Faculty on Thomson Reuters “Highly Cited Researchers” list for 2017

January 18, 2018

Congratulations to M&I faculty members Edward Miao, Jenny Ting, Ralph Baric, and Wesley Burks for making the “Highly Cited Researchers” list compiled annually by Thomson Reuters: “These researchers have distinguished themselves by publishing a high number of papers that rank in the top 1% most-cited in their respective fields over a recent 11-year period. Such … Read more

Conlon lab: Altering antibiotic susceptibility in chronic co-infections

December 15, 2017

  CHAPEL HILL NC – Scientists at the UNC School of Medicine have found that a bacterium can become much more or less susceptible to an antibiotic depending on the specific bacterial community in its midst. The scientists found specifically that the bacterium Pseudomonas aeruginosa can produce specific molecular factors that dramatically increase or decrease … Read more

The rebirth of Mary Ellen Jones

December 10, 2017

For nearly four decades, the Mary Ellen Jones Building (originally called FLOB for Faculty Laboratory Office Building) was home to the Department of Microbiology & Immunology. Part of the renovation process is a complete facelift to make her appear as if she’s the sister of Marsico Hall, where most of M&I now lives. The photos … Read more

Blossom Damania named as AAAS Fellow

December 3, 2017

  The Council of the American Association for the Advancement of Science has announced that Blossom Damania, Professor of Microbiology & Immunology, has been selected to be a 2017 AAAS Fellow. Each year, the Council considers thousands of nominations from all branches of science and selects Fellows from those whose “efforts on behalf of the … Read more

Goonetilleke lab: Therapeutic vaccine for HIV

August 24, 2017

  M&I Assistant Professor Nilu Goonetilleke will head an NIH U01-sponsored multidisciplinary research effort to test a therapeutic vaccine in people living with HIV. Strengthening and redirecting the immune system’s anti-HIV response are the primary goals of the $5.6M five-year study. “The first generation of this vaccine produced an impressive immune response in people living … Read more